Development of self-emulsifying drug delivery systems (SEDDS) for ciprofloxacin with improved mucus permeating properties. 2018

Sergey Zaichik, and Christian Steinbring, and Claudia Menzel, and Ludwig Knabl, and Dorothea Orth-Höller, and Helmut Ellemunter, and Katharina Niedermayr, and Andreas Bernkop-Schnürch
Department of Pharmaceutical Technology, Institute of Pharmacy, Leopold-Franzens- University Innsbruck, Innrain 80/82, Innsbruck, Austria.

The aim of this study was to develop a self-emulsifying drug delivery system (SEDDS) containing the fluoroquinolone antibiotic ciprofloxacin (CIP) exhibiting highly mucus permeating properties and antimicrobial activity in in vitro models. Various SEDDS formulations were developed and evaluated regarding droplet size, polydispersity index, zeta potential and formulation stability. Furthermore, SEDDS permeating properties were investigated in porcine intestinal mucus, as well as in cystic fibrosis (CF) sputum freshly collected from CF patients using Transwell® setup and single particle tracking (SPT), respectively. In order to evaluate antibacterial activity in an in vitro model against Staphylococcus aureus and other pathogens, minimum inhibitory concentrations (MIC) and time-kill curves were determined. In addition, in vitro release of ciprofloxacin and cytotoxicity studies were conducted. The preselected formulations F1 and F11 exhibited a mean droplet size of 79 nm and 25 nm, respectively, and a negative zeta potential. SEDDS containing CIP exhibit improved ability to permeate porcine intestinal mucus and CF sputum. After 4 h, F1-CIP formulation resulted in a 1.6 - fold and F11-CIP a 2.0 - fold higher amount of permeated ciprofloxacin through the sputum layer with respect to free CIP. Moreover, the antimicrobial activity of F11-CIP against S. aureus was higher than that of free CIP. According to these results, SEDDS formulations should be taken into consideration as promising delivery systems for the treatment of pulmonary infections accompanied by mucus dysfunction.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D004655 Emulsions Colloids formed by the combination of two immiscible liquids such as oil and water. Lipid-in-water emulsions are usually liquid, like milk or lotion. Water-in-lipid emulsions tend to be creams. The formation of emulsions may be aided by amphiphatic molecules that surround one component of the system to form MICELLES. Emulsion
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Sergey Zaichik, and Christian Steinbring, and Claudia Menzel, and Ludwig Knabl, and Dorothea Orth-Höller, and Helmut Ellemunter, and Katharina Niedermayr, and Andreas Bernkop-Schnürch
January 2018, Colloids and surfaces. B, Biointerfaces,
Sergey Zaichik, and Christian Steinbring, and Claudia Menzel, and Ludwig Knabl, and Dorothea Orth-Höller, and Helmut Ellemunter, and Katharina Niedermayr, and Andreas Bernkop-Schnürch
January 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,
Sergey Zaichik, and Christian Steinbring, and Claudia Menzel, and Ludwig Knabl, and Dorothea Orth-Höller, and Helmut Ellemunter, and Katharina Niedermayr, and Andreas Bernkop-Schnürch
April 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Sergey Zaichik, and Christian Steinbring, and Claudia Menzel, and Ludwig Knabl, and Dorothea Orth-Höller, and Helmut Ellemunter, and Katharina Niedermayr, and Andreas Bernkop-Schnürch
May 2019, International journal of pharmaceutics,
Sergey Zaichik, and Christian Steinbring, and Claudia Menzel, and Ludwig Knabl, and Dorothea Orth-Höller, and Helmut Ellemunter, and Katharina Niedermayr, and Andreas Bernkop-Schnürch
December 2018, Journal of colloid and interface science,
Sergey Zaichik, and Christian Steinbring, and Claudia Menzel, and Ludwig Knabl, and Dorothea Orth-Höller, and Helmut Ellemunter, and Katharina Niedermayr, and Andreas Bernkop-Schnürch
March 2018, International journal of pharmaceutics,
Sergey Zaichik, and Christian Steinbring, and Claudia Menzel, and Ludwig Knabl, and Dorothea Orth-Höller, and Helmut Ellemunter, and Katharina Niedermayr, and Andreas Bernkop-Schnürch
January 2009, Critical reviews in therapeutic drug carrier systems,
Sergey Zaichik, and Christian Steinbring, and Claudia Menzel, and Ludwig Knabl, and Dorothea Orth-Höller, and Helmut Ellemunter, and Katharina Niedermayr, and Andreas Bernkop-Schnürch
January 2014, Critical reviews in therapeutic drug carrier systems,
Sergey Zaichik, and Christian Steinbring, and Claudia Menzel, and Ludwig Knabl, and Dorothea Orth-Höller, and Helmut Ellemunter, and Katharina Niedermayr, and Andreas Bernkop-Schnürch
January 2001, International journal of pharmaceutics,
Sergey Zaichik, and Christian Steinbring, and Claudia Menzel, and Ludwig Knabl, and Dorothea Orth-Höller, and Helmut Ellemunter, and Katharina Niedermayr, and Andreas Bernkop-Schnürch
January 2008, AAPS PharmSciTech,
Copied contents to your clipboard!